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Effectiveness of Pediatric Pill Swallowing Interventions: A Systematic Review 
	  
Abstract: 
Objective: Pediatric patients commonly have barriers to taking oral medications due to pill 
swallowing. Targeted interventions to improve pill swallowing have been reported to 
improve both medication administration and treatment compliance. The review’s objective 
is to evaluate studies performed on pill swallowing interventions in the pediatric populations 
since 1987. 
Methods: We performed a comprehensive PubMed search for studies published in English 
between December 1986 and December 2013 that included >10 participants ages 0-21 years 
with pill swallowing difficulties who did not have a comorbid condition affecting their swallowing. 
Reviewers then rated the quality of each study as “poor” “fair” and “good” based on the sample 
size, study design, measurement bias, selection bias, and confounding. 
Results: We identified 5 articles that met our inclusion/exclusion criteria; 4 prospective cohort 
studies and 1 retrospective cohort study with sample sizes ranging from 11-124 patients. 
Overall, all of the studies found their intervention to be successful in teaching children how to 
swallow pills and included behavioral therapies, flavored throat spray, simple verbal instructions, 
a specialized pill cup, and head posture training. Study ratings differed with 3 articles rated as 
“fair”, 1 article rated as “good”, and 1 article rated as “poor.”  
Conclusions: Addressing pill swallowing difficulties via targeted interventions can improve 
medication administration and compliance in the pediatric population. More research is needed 
to support these interventions including more high quality studies that evaluate and compare the 
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Introduction: 
The pediatric population has a unique set of barriers to oral medication compliance and 
administration. One common barrier is children’s inability to swallow pills. Factors that can affect 
a child’s ability to swallow pills include developmental stage, fear, anxiety, intolerance of 
unpleasant flavors, and failure to appreciate the risks associated with non-compliance. A survey 
of 304 parents showed that 30-40% had children who rejected or refused a pill or liquid 
medication, and more than 50% had children who were unable to swallow a standard size pill or 
small capsule.1 Other studies have found that struggles in pill swallowing can extend into 
adolescence and can have significant detrimental effects for those with chronic illnesses.2,3 In 
2008, Hansen et al. interviewed 89 adolescents aged 11-20 about their struggles with 
swallowing tablets.2 Over one-third of the adolescents reported difficulties with swallowing pills 
due to factors such as taste, size, feelings, and bodily discomfort.2  Another study done in 2010 
by Hommel and Baldassano found that difficulty swallowing pills was one of the most common 
identified barriers in treatment adherence for adolescents with inflammatory bowel disease.3 
The commonality of pill swallowing problems in children and its detrimental effect on compliance 
and administration call for targeted interventions to help children swallow pills.  
 In 1987, Pelco et al. reviewed the relevant literature regarding interventions to address 
pill swallowing difficulties in children.4 The authors found five studies that used behavioral 
techniques such as instruction, modeling, positive and negative reinforcement, and shaping to 
help children swallow pills.4–9 All of the studies reported routine pill acceptance shortly after their 
intervention, and three of the studies reported continued pill acceptance 3-6 months after the 
intervention.4–9 Unfortunately, all of the studies mentioned in the review had small sample sizes 
ranging from 1-6 children.4–9 Thus, knowledge regarding the effectiveness of the tested 
interventions was limited. 
 Since the 1987 review, a variety of interventions have been developed and studied to 
help children develop skills in swallowing pills. These interventions include behavioral therapies, 
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flavored throat spray, simple verbal instructions, a specialized pill cup, and head posture 
practices.10–14 The goal of this systematic review is to summarize the published literature since 
1987 that focuses on the effectiveness of various pill swallowing training interventions and aids 
in the pediatric population.  
 
Methods: 
Data Sources and Search Strategy 
We performed a comprehensive PubMed search to identify all of the relevant articles for 
our main study question. Our final search strategy included the following MeSH terms (*) and 
keywords: “(Deglutition* OR Swallowing) AND (Child* OR Children OR Pediatric OR Pediatrics*) 
AND (Oral administration* OR Capsule OR Capsules* OR Tablet OR Tablets* OR Pill OR 
Pills).” In order to ensure that our search strategy was adequate, we identified 2 sentinel articles 
from a previous literature search.11,12 Both of these articles were found in our search results. We 
reviewed titles of all identified articles to find those that studied our topic of interest and met our 
inclusion criteria as described below. These results were further filtered with abstract reviews 
and full-text screens. Lastly, we reviewed reference lists of the final articles to find any additional 
studies that met our inclusion criteria.  
 
Study Selection and Data Abstraction 
Figure 1 presents our flow diagram of study retrieval and selection. We restricted our 
search strategy to include articles that were published in English between December 1986, just 
prior to the last review, and December 2013.4 Our population of interest included pediatric 
patients ages 0-21 with pill swallowing difficulty. We excluded papers that focused on children 
with a diagnosis of dysphagia or any other condition associated with swallowing dysfunction 
such as severe developmental disabilities.  We included all types of pill swallowing interventions 
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and focused on randomized control trials and cohort studies. We excluded case control studies 
and only included studies with >10 subjects. 
Our main outcome of interest was whether or not participants who received the 
intervention successfully and consistently swallowed pills. In addition, we were interested in the 
long-term effects of the intervention for children’s pill swallowing abilities after the study was 
complete.   We extracted the necessary data from the included article. We recorded the year of 
publication, study question, study population, study design, main intervention, and overall 
results or conclusion for each of the final articles. Next, the authors performed a quality 
assessment for each of the articles by evaluating their internal validity. The articles were rated 
as “good”, “fair, or “poor” based on the study’s design, sample size, and potential for selection 
bias (rated + to +++), measurement bias (rated + to +++), and confounding (rated + to +++). 




We initially identified 211 articles from the PubMed search (Figure 1). We excluded 35 
articles not published in English, 155 articles after screening the titles for relevance, and 11 
articles after reviewing the abstracts for relevance. We excluded 6 studies with a sample size of 
<10 participants. We added one article via a bibliography review, so our final list for this review 
consisted of 5 articles (Figure 1).10–14  
 
Study Design & Study Populations 
 The main characteristics of our final 5 articles are summarized in Table 1. We found no 
randomized trials. The included studies consisted of 4 prospective cohort studies and 1 
retrospective cohort study.  Two of the articles specifically studied children diagnosed with 
HIV.10,11 Czyzewski et al. studied 29 children with Human Immunodeficiency Virus (HIV) aged 3-
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13 years who were either new to pill swallowing or had reported difficulties swallowing pills.10 
Garvie et al. studied 23 children with HIV aged 4-21 years who either had difficulty swallowing 
their current medication regimen or were preparing for a change in their medication formulary.11 
Meltzer et al. studied a cohort of 124 children aged 6-11 years who were healthy or had a 
dermatologic and/or a respiratory condition.14 This population included children who were able 
to swallow pills and children who were unable to swallow pills.14 Diamond et al. studied 11 
adolescents aged 9-17 years who self-reported past difficulty swallowing tablets or capsules.12 
Lastly, Kaplan et al. studied 41 children aged 2-17 who were never able to successfully swallow 
medications in the past.13 Most of the children in this study were referred from an advertisement 
in a tertiary care pediatric hospital.13 The remainder of the children in this study were either 
siblings or friends of the clinic patients or were the hospital staff’s children.13 
 
Study Interventions 
All of the articles studied the effects of various interventions on improving pill swallowing 
abilities in children (Table 1). The Czyzewski et al. and Garvie et al. studies used a behavioral 
intervention that included shaping and modeling.10,11 The study by Meltzer et al. provided 
scripted swallowing instructions with an ordinary cup or pill cup depending on the child’s 
needs.14 Diamond et al. studied the effects of a lubricated flavored spray that helps children 
swallow by coating the back of their mouths and tongues.12 Lastly, Kaplan et al. taught children 
5 different head positions and provided a brief education about the esophagus along with 
reassurance to improve pill swallowing skills.13  
 
Study Results 
 In general, all of the studied interventions improved pill swallowing abilities in the 
majority of their study population (Table 1). Czyzewski et al. found that 17 of the 29 children in 
their study were able to swallow large capsules and maintain adherence to their medication 
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regimen for ≥ 6 months after the behavioral intervention.10 In the Meltzer et al. paper, 47 of the 
67 children who were initially unable to swallow pills learned the skill via scripted instructions 
with an ordinary cup, and 9 additional children learned the skill via scripted instructions with a 
pill cup.14 Garvie et al. found that 22 of the 23 children in their study not only learned to 
successfully swallow pills after the behavioral intervention but also had significant improvements 
in their CD4 counts and viral load at 6 months.11 In the study by Diamond et al., the lubricated 
flavored spray was found to be effective in improving the ability to swallow a small candy in 7 
out of the 11 adolescent participants.12 Finally, in the Kaplan et al. study, 33 of the 41 children 
completed the 2-week practice protocol after being taught 5 different head positions.13 All 33 of 
these children were able to successfully swallow pills after completing their practice regimen.13  
 
Quality of Studies 
 Quality characteristics of the selected studies are summarized in Table 2. Overall, 1 
study was rated as “good”, 3 studies were rated as “fair”, and 1 study was rated as “poor.” There 
were a number of common limitations for the selected articles in this review. First, all of the 
selected articles were observational cohort studies. As a result, the studies were all vulnerable 
to significant bias due to potential confounding and lack of controls. Another limitation was the 
lack of consistency in measuring whether or not participants were able to successfully swallow 
pills after the intervention. Although a few articles had a relatively rigorous method to assure 
their participants had acquired this skill, the lack of consistency among the articles made it 
difficult to compare the effectiveness of the various interventions. Lastly, all of the articles had 
small sample sizes. Our largest study only had 67 children who actually needed and received 
the intervention.14 Therefore, the conclusions made in these articles must be taken with caution.  
The Diamond et al. study was rated as “poor” due to concerns regarding its very small 
sample size, method of sample selection, measurement of outcome, and lack of consistency in 
the use of the intervention.12 The Czyzewski et al., Meltzer et al., and Garvie et al. studies were 
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rated as “fair.”10,11,14 The Czyzewski et al. study had concerns regarding selection bias and 
possible measurement bias.10 A major strength of the study, however, was the detailed 
intervention protocol to ensure standardization.10 The Meltzer et al. study had a large and 
diverse sample of pediatric patients, but the study’s outcome assessments for ease of 
swallowing and ability to swallow medication had the potential for significant measurement 
bias.14 The Garvie et al. study had robust measurements for adherence to medication and pill 
swallowing ability.11 Unfortunately, selection bias was a major concern in this study given its 
retrospective design.11 Lastly, the Kaplan et al. study was the only article that was rated as 




In the last 26 years, from 1987 to 2013, there have only been 5 published studies on pill 
swallowing interventions that meet our criteria for inclusion.  This paucity of data demonstrates 
the need for more high-quality studies on this topic. Nevertheless, our review does show that 
the inability to swallow pills is a barrier that can be overcome in the pediatric population. All of 
the selected articles in this review demonstrated that their intervention was successful in 
improving pill swallowing abilities in more than half of their study population. Furthermore, the 
articles showcased a number of different strategies that a healthcare provider can use to 
facilitate the development of pill swallowing skills. The interventions in this review include 
behavioral therapy, flavored throat spray, specialized pill cup, simple verbal instructions, and 
head posture training. With such a plethora of available interventions, the interventions used for 
a specific child with pill swallowing difficulties may be tailored to overcome that child’s 
underlying reason for not being able to swallow pills.  
 In addition, this review provides insight into the appropriate age range for swallowing 
pills. Parents who are concerned that their children are too young to swallow pills can be 
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assured that some of the interventions have been studied in children as young as two years 
old.13 In fact, one study found that younger children (age 4-5 years) needed less training 
sessions than older children to learn how to swallow pills.11 The authors of the study believed 
that this was due to younger patients having fewer negative experiences when attempting to 
swallow pills in the past than older patients.11 Therefore, teaching children how to swallow pills 
at an earlier age can prevent future barriers to medication adherence and can potentially be 
easier than waiting until they are older.    
 
Limitations 
There were a few limitations in our systematic review. First, we only searched one 
database (PubMed) for articles on pill swallowing interventions. In addition, we limited our 
search to articles that were published in English and that had >10 participants. All of these 
factors could have potentially resulted in us excluding important articles pertaining to our main 
topic of review. Furthermore, we excluded studies focusing on children with a comorbid 
condition that affected their swallowing skills such as severe developmental disabilities. 
Consequently, the generalizability of this review is limited to children who do not have 
dysphagia and are developmentally appropriate.  Lastly, our method of appraising the quality of 
the studies could be vulnerable to bias. However, our review had multiple authors independently 
appraise these articles, thus limiting this concern.  
 
Conclusion: 
The inability to swallow pills is a common and important barrier to medication 
administration for children and their parents. Thus, addressing pediatric pill swallowing 
difficulties via targeted interventions has the potential to improve both medication administration 
and treatment compliance. These interventions can include but are not limited to behavioral 
therapy, flavored throat spray, specialized pill cup, simple verbal instructions, and head posture 
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training. Unfortunately, studies that evaluate the effectiveness of various pill swallowing 
interventions are limited due to their small sample sizes, observational study design, and lack of 
controls. 
A prospective randomized control trial would allow for more confident conclusions about 
the effectiveness of the various interventions, allow for comparisons among multiple 
interventions, and reduce the potential for selection or recall bias. Given the increasing 
emphasis on transition from intravenous to oral therapy for many conditions, this type of study 
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- 29 children with HIV 
aged 3-13 years 
- Children were either 
new to pill swallowing 







- Trainers were 
clinical psychology 
interns and trainees  
- Sessions usually 
lasted <30 min 
- 17 children were able to 
swallow large capsules 
and maintained 
adherence to their 
protease inhibitor for ≥ 6 
months  
- Most successful cases 






- 124 children aged 
6-11 years  
- Children were either 
healthy or had a 
dermatologic and/or 





ordinary cup OR pill 
cup  
- Initially, 67 children 
noted that they were 
unable to swallow pill.  
- 47 children learned with 
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- 9 children learned with 





- 23 children with HIV 
aged 4-21 years  
- Children were 
referred for difficulties 
with adherence to 
medication regimen 







- Trainers were 
clinical pediatric 
psychologists  
- Sessions were ≤ 
30 min  
- 22 children were able to 
successfully swallow pills 
with training 
- Modal number of 
sessions needed = 1   
- Significant 
improvements in 
adherence, CD4 counts, 
and viral load were seen 




cohort study  
- 11 adolescents 
aged 9-17 years 
- Participants who 
self-reported past 
difficulty with 
swallowing tablets or 
capsules  
- Lubricated 
flavored spray that 
coats the back of 
the mouth and 
tongue 
-7 children were able to 
swallow a small candy 
successfully with spray  
- The majority of 
successful children only 






- 41 children aged 2-
17 years 
- Participants were 
referred from an 
advertisement in a 
tertiary care pediatric 
hospital, were 
siblings/friends of 
clinic patients, or 
were the hospital 
staff’s children 
- All children were 
never able to 
successfully swallow 
a pill in the past 
- Teaching of 5 
head positions 
(center, up, down, 
left, and right) 
along with 2 
minutes of 
reassurance and 
education about the 
esophagus   
- The first session 
was usually 45 min 
- The session was 
followed by 2 
weeks of daily 
practice with candy 
- All 33 children who 
completed the 2 week 
practice regimen were 
able to successfully 
swallow pills  
- 29/33 were able to 
swallow pills in all 5 
positions  
- 8 children withdrew from 
the study due to lack of 
practice with 4/8 children 
being too ill to continue 
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The Pediatric Oral Medications Screening (POMS) Study 
 
Abstract: 
Objective: Difficulties with swallowing medicine is a common barrier in oral medication 
administration and compliance. Given the importance of early transition to oral medication to 
reduce treatment-related complications, our goal is to identify children with oral medication 
swallowing difficulties early in their hospital stay in order to provide them with timely inpatient 
interventions. By teaching children how to swallow medicines, we hope to optimize their quality 
of care and eventually decrease healthcare costs associated with intravenous medications.  
Methods: We screened 34 general inpatient pediatric patients on their oral medication taking 
abilities from April 2014 to June 2014. Patients who did not meet their age goals were referred 
to pediatric recreational therapists for medication swallowing interventions (POMS+). Children 
were then post-screened to assess improvement after the POMS+ intervention. A separate 
retrospective chart review was done to assess the prevalence of PICC line placements and the 
average length of stay for general inpatient pediatric patients at UNC Children’s Hospital from 
January 2010 to December 2013.  
Results: Approximately 18% (6 out of 34) of our study population did not pass the oral 
medications screening test. Of the patients who did not pass our screen, 50% (3 out of 6) 
successfully completed our POMS+ intervention and showed noteworthy improvements in their 
medication taking abilities. Children who did not pass the screen were significantly different than 
children who did pass the screen on the following measures: parent-reported anxiety rating, 
child-reported rating on how taking medicine by mouth makes them feel, and proportion of 
children with previous or current Psychiatric/Psychological services.  
Conclusions: Screening pediatric patients in the hospital about their ability to swallow oral 
medications is an effective way to identify children who may benefit from medication swallowing 
interventions and to facilitate early transition to oral medications. As a result, this screening 
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protocol can improve the quality of care we provide our pediatric patients and can decrease 
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Introduction: 
The pediatric population has a unique set of barriers to medication compliance and 
administration. One common barrier is children’s inability to swallow oral medications. Factors 
that affect a child’s ability to swallow medications can include developmental stage, fear, 
anxiety, intolerance of unpleasant flavors, and failure to appreciate the risks associated with 
non-compliance. Furthermore, struggles in medication swallowing can extend into adolescence 
and can have detrimental effects for those with chronic illnesses.1,2 Therefore, interventions 
targeted to help children swallow medicine could significantly improve medication compliance 
and administration in the pediatric population.  
In addition to better medication compliance, improving a child’s oral medication 
swallowing ability can minimize the risks associated with intravenous (IV) therapy without 
sacrificing treatment efficacy. Past studies have found that an early transition from IV to oral 
antimicrobial therapy can reduce treatment complications, length of stay, and readmission rates 
for children.3–6 Furthermore, the increased costs and workload associated with IV antibiotics can 
pose a burden on both patients’ families and hospital staff.7 Hence, being able to offer oral 
medications to children is beneficial medically, financially, and practically.  
Multiple types of interventions have been found to be effective in helping children 
overcome their difficulties with swallowing medicine.8–12 They include head posture practice, 
behavioral therapy, lubricated mouth spray, simple verbal instructions, and a specialized pill 
cup. 8–12 These intervention can not only improve children’s medication swallowing abilities but 
can also result in improvements in treatment adherence and chronic disease management.10 
Therefore, offering targeted and timely interventions to children with known difficulties 
swallowing medicine can help alleviate the burdens associated with this barrier.  
 The major goal of our study is to determine whether screening children in the hospital 
regarding their oral medication taking ability and providing them with timely inpatient 
interventions can reduce the number of children on IV therapy and expedite discharge from the 
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hospital. In turn, we hope this will help reduce healthcare costs associated with prolonged 
hospital stays and home IV therapy for this population. In addition, we hope this intervention will 
improve the quality of care that is delivered to inpatient pediatric patients by reducing the 
complications of IV medication and the anxiety associated with taking oral medications.  
 
Methods:  
All parts of this study are approved by the University of North Carolina Institutional Review 
Board (#13-3046).  
 
Retrospective Chart Review: 
We obtained patient information from UNC Children’s Hospital’s computer-based 
medical and billing records for all children aged 3-17 admitted in the Child Generalist or 
Pediatric Hospitalist services between January 2010 and December 2013. Children diagnosed 
with a pre-selected list of conditions were included in the analysis (Appendix 1). We abstracted 
the children’s age, gender, primary diagnosis during the last date of service, length of stay, and 
whether or not they had a peripherally inserted central catheter (PICC) line placed. We 
calculated the average age, the proportion of males, the average length of hospital stay, and the 
proportion of children with a PICC line using this data.  
 
Study Participants: 
We identified study participants by reviewing a computer-based general pediatric 
inpatient census at the University of North Carolina’s Children’s Hospital between April 2014 
and June 2014. The census was reviewed every Monday through Thursday. Patients were 
eligible for the study if they were between 3 to 17 years old at admission and were admitted to 
the general pediatrics team with an estimated length of stay of 3 days or more.   
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We also had a number of exclusion criteria to ensure that our participants did not have a 
comorbid condition that affected their swallowing abilities. We excluded children who: 1) had an 
altered mental status 2) were developmentally delayed 3) had a neuromuscular abnormality that 
affected their swallowing function 4) had a head or neck lesion that affected their swallowing 
function 4) had a history of dysphagia 5) were unable to participate due to current medical 
illness severity 6) had a significant Psychiatric disorder or 7) were NPO status. Patients who 




Parents and children were first asked to fill out our POMS Paper and Pencil Survey 
Questionnaire© before the start of the intervention (Figure 1). The questionnaire was designed 
to assess parental perception of their child’s anxiety about taking medicines, to report any past 
difficulties their child had with taking oral medications, and to report if their child received 
previous or current Psychiatric/Psychological services. In addition, the questionnaire asked 
patients if they found addressing medication-taking in the hospital to be useful. Lastly, the 
questionnaire asked children directly how they felt about taking oral medications using a 5-point 
scale (1 = “two thumbs up” and 5 = “two thumbs down”). Parents were also asked to indicate 
which levels (liquid, small pill, medium pill, and large pill) they believed their children could 
successfully swallow using the provided images on our POMS card© (Figure 2). 
Next, children were screened by swallowing placebo liquid and up to 3 placebo pill sizes 
(Figure 3). The liquid solution was a mixture of the Ora-Plus® oral suspending vehicle and the 
Ora-Sweet® sugar-free syrup by Perrigo®. The placebo pills consisted of 1-grain and 5-grain 
homeopathy blank tablets and “o” size empty capsules. The parents and children were 
instructed to use whatever method they usually use to take oral medications when at home. The 
participants had 30 minutes to complete the screening test, and the results along with any 
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adverse events were documented on the POMS card. The goal for each participant was based 
on his or her age (Table 1). For patients who met their age goals, participation in the study was 
complete.  Patients who did not meet their age goals were referred to our POMS+ intervention.  
 
POMS+ Intervention 
Two licensed pediatric recreational therapists performed the POMS+ intervention by 
using the following techniques: medical play, developmental play, procedural support/practice, 
relaxation training, discharge planning, and pill-cup use. The number of sessions and the 
techniques used were documented on the POMS+ card (Figure 2). 
 
Follow-up 
After completion of the intervention, patients were re-screened using the same method 
as mentioned previously using a sample liquid and up to 3 sample pill sizes. Results were 
recorded on the POMS+ card. All participants were notified that they would be contacted via a 
brief follow-up phone call 4-6 months after the intervention to assess the long-term effects and 
overall satisfaction with the POMS+ intervention (Table 2).  
 
Statistical Analysis:  
We described the overall sample by calculating the following: average age, percentage 
of males, average parent-reported child anxiety rating, percentage of children with past difficulty 
with oral medications, percentage of parents who believed addressing medication-taking in the 
hospital is helpful, percentage of children with previous or current Psychiatric/Psychological 
services, and the average child-reported rating on how taking medicine by mouth makes them 
feel.  We also calculated the percentage of patients who passed the initial screen.  
Next, we compared patients who passed our initial screen to patients who did not pass 
our initial screen. We used a type 2 two-tailed two-sample t-test to compare the average age, 
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the average parent-reported child anxiety rating, and the average child-reported rating on how 
taking medicine by mouth makes them feel.  We used both a chi-squared test and Fisher’s 
exact test due to our small sample size to compare the percentage of males, the percentage of 
children with past difficulty with oral medications, the percentage of parents who believed 
addressing medication-taking in the hospital is helpful, and the percentage of children with 
previous or current Psychiatric/Psychological services. 
 
Results:  
Retrospective Chart Review Results 
We had a total of 562 patients between January 2010 and December 2013 who met our 
criteria in the retrospective chart review. The average age of the patients at admission was 8.93 
years, and 56.05% of the patients were males. The list of final diagnoses and the number of 
patients with each diagnosis can be found in Appendix 2. The most common diagnoses were 
“Fever Unspecified” (233 patients), “Pneumonia, Organism Unspecified” (101 patients), 
“Cellulitis & Abscess Leg Except Foot” (40 patients), and “Systemic Lupus Erythematous” (31 
patients). The average length of stay for our patients was 7.78 days. The prevalence of PICC 
placement in this population was 6.77% (38 patients).  
 
POMS Results  
Study Sample Demographics 
 We screened 34 patients in our study.  The average age of the participants was 10.09 
years, and approximately 38% of the participants were male (Table 3). The age of our 
participants ranged from 3 to 17 years (Figure 4). On average, parents reported their child’s 
anxiety about taking medicines at 2.15. This was similar to the average rating of 2.06 reported 
by children on how taking medicine by mouth makes them feel. 38.24% of participants had 
trouble with oral medications in the past, and 23.53% of participants had previous or current 
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Psychiatric/Psychological services. An overwhelming majority of parents (33 of 34 parents) 
believed that addressing medication-taking in the hospital is helpful.  
 
Patients Who Passed vs. Patients Who Did Not Pass 
 A total of 6 patients (17.65%) did not pass our initial screen. Table 3 compares the 
patients who passed to the patients who did not pass, and Figure 5 displays the age distribution 
of the two groups. There was no significant difference in the average age (p=0.876) and gender 
composition (p=0.231, 0.370) between the two populations. Children who did not pass reported 
a higher rating on how taking medicine by mouth makes them feel than children who passed, 
but this difference was not statistically significant (p=0.099). However, there was a significant 
difference in the parent-reported anxiety rating for children who did not pass versus children 
who did pass (p=0.026) (Figure 6). There was also a significant difference between the two 
populations in the proportion of children with past trouble taking oral medications (p=0.012, 
0.021) and the proportion of children with previous or current Psychiatric/Psychological services 
(p=0.006, 0.018) (Figures 7 and 8).  
  
POMS+ Patients 
 Three patients who did not pass the screen successfully completed the POMS+ 
intervention (Table 4). ). These patients included a 16-year-old female with sinusitis that 
progressed to meningitis and a cerebellar abscess requiring operative drainage, an 8-year-old 
male with a retropharyngeal abscess requiring incision & drainage, and a 6-year-old female 
admitted for revision of her ureterostomy. All three patients showed notable improvements in 
their ability to swallow pills during their post-screen. Both the 8-year-old patient and the 6-year-
old patient had a reported history of significant anxiety with taking medicine and were unable to 
swallow pills before this intervention. As a result of this intervention, the 8-year-old patient was 
able to go home without a PICC line to complete his medication regimen, and the 6-year-old 
Amee Patel 
Page  25 
patient was able to transition to oral medications without using her G-tube. Both patients 
showed excitement and confidence in their new abilities after working with the recreational 
therapists. 
 
Patient Dropouts  
 Three patients who did not pass the screen dropped out of the study. The patients were 
8, 10, and 11 years of age. Two patients declined any POMS+ interventions after the initial 
screen. One patient discontinued participating after one POMS+ session to focus on her main 
reason for admission. The patient who completed one POMS+ session, however, requested 
take-home material to practice pill swallowing techniques after recovering from her illness.  
 
Patients Who Declined  
We had 18 patients who declined to participate in our study.  The average age (p=0.918) 
and gender composition (p=0.414, 0.557) of patients who declined to participate did not differ 
significantly from patients who were screened (Table 5). Common reasons for not participating 
included the child already knowing how to swallow medicine, the child not feeling well enough to 
participate (i.e. pain or nausea), the family not wanting to increase the child’s anxiety, and the 
family wanting to focus on the main reasons for admission.  
 
Discussion: 
 The goal of this study was to determine whether screening inpatient pediatric patients 
regarding their oral medication taking ability and providing them with timely inpatient 
interventions can reduce the number of children on IV therapy and expedite discharge from the 
hospital. Our study confirmed that taking oral medications is a difficult and stressful task for a 
significant proportion of pediatric patients and their families. Almost 18% of our study sample did 
not pass our initial screen that tested their ability to swallow medicines. However, this may be 
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an underestimate of the true prevalence since a number of parents declined to participate in our 
study despite reporting that their child had difficulties with swallowing medicine. In addition, our 
retrospective analysis found that almost 7% of children admitted to UNC’s inpatient pediatrics 
unit received a PICC line. Teaching children how to swallow medicine can be an effective way 
to decrease the percentage of children on a PICC line for IV therapy.  
Overall, the POMS+ intervention was very effective at teaching children how to swallow 
oral medications. All three of the POMS+ patients showed significant improvements after the 
intervention, and they only required one to two sessions before seeing visible improvements. 
One patient was going to be discharged on home IV medications with a PICC line due to his 
severe anxiety about swallowing pills, but after participating in our study, he was able to 
successfully swallow level 3 pills and was discharged on oral antibiotics. Another patient with a 
chronic condition requiring multiple medications per day was also unable to swallow pills and 
had to take unpleasant liquid medication or have her medication administered via a G-tube. 
However, with the help of our study, the patient was able to successfully swallow level 2 pills 
and was transitioned to pills during discharge.  
We did face some limitations while conducting this study. First, our sample size was 
small with only 34 patients, but we adjusted for this in our statistical analysis by using both a chi-
squared test and a Fisher’s exact test when appropriate. We may consider expanding our 
eligibility criteria in the future. Another limitation was that 3 of the 6 patients who did not pass 
our initial screen dropped out of the study. Although these patients did not complete our study, 
we believe our study was still useful to them because it made their parents aware of the fact that 
pill swallowing difficulties can be overcome. One family even requested take-home material to 
teach their child how to swallow pills after she recovered from her illness. Lastly, we relied on a 
convenience sample of inpatient pediatric patients and only recruited on weekdays. However, 
we do not believe that children we missed due to this method of sample selection were 
significantly different than our study sample.  
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The intervention used in this study incorporated multiple different strategies to teach 
children how to swallow medicines. Many of these strategies such as behavioral therapy with 
shaping and head posture practice have been found to be successful in past studies.8–12 
However, the number of studies published on oral medication swallowing is still very limited. 
Due to the paucity of data, we hope that this study can contribute significantly to this topic and 
provide more information to healthcare providers on how to help children with difficulties taking 
oral medication. Furthermore, we hope to contact all of the patients who received the POMS+ 
intervention 4-6 months after the study to assess whether the intervention resulted in long-term 
improvements. In addition, we hope to perform a thorough cost analysis to determine the 
financial benefits of this screening program. Eventually, we hope that oral medication screening 
will become a routine practice for all pediatric patients in the hospital so that we can offer timely 
inpatient interventions to those in need. 
 
Conclusion: 
 The inability to swallow oral medications is a common problem in the pediatric 
population. Screening children about their oral medication swallowing abilities early in their 
hospital admission is an effective way to identify children who may benefit from targeted 
medication swallowing interventions. This screening protocol can facilitate early transition to oral 
medications and has the potential to decrease the number of children who need a PICC line for 
IV therapy. Not only would this improve the quality of care we can provide children, but it would 
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Table 1: Medication Swallowing Goals Based On Age  
Age Category Medication Swallowing Goal  
3-5 years Only liquid medication (POMS Level 1) 
6-10 years Liquid + small/medium pills (POMS Level 3) 
10+ years Liquid + small/medium/large pills (POMS Level 4) 
 
 
Table 2: Questions Asked During Phone Call Follow-Up 
Follow-Up Questions 
1) Was your child able to complete his/her medication regimen after 
discharge? If not, when did your child stop taking his/her medication and why? 
(compliance, adverse events, etc.…) 
2) Overall, please rate the ease in administrating the discharge medication to 
your child (1-5 with 5 being “very easy”)  
3) Have there been instances since your discharge when you believe the 
screening program has affected your child in a positive or negative way? 
4) Overall, please rate your satisfaction level with the pediatric oral medication-
screening program? (1-5 with 5 being “very satisfied”) 
 
 
Table 3: Demographics & Questionnaire Results of Screened Patients 
 All Patients Passed  Did Not Pass P-value 
Average age (years) 10.09 10.14 9.83 0.876* 
% Male 38.24 40.74 16.67 0.231; 0.370** 
Average parent-reported 
anxiety rating 
2.15 1.89 3.33 0.026* 
% with past trouble taking 
oral medications 
38.24 28.57 83.3 0.012; 0.021** 
% with parents who think 
addressing medication-
taking is the hospital is 
helpful 
97.06 96.43 100.0 0.638; 1.000** 
% with previous or current 
Psych services 
23.53 14.29 66.67 0.006; 0.018** 
Average child-reported 
rating on how taking 
medicine by mouth makes 
them feel 
2.06 1.88 2.83 0.099* 
* P-value based on a tow-tailed two-sample t-test (assuming equal variance) 
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Table 4: POMS+ Patients 
Age Gender Pre-Screen 
 




16 F Level 3 Level 4 
Procedural support, 
relaxation training, practice 
with candies, head 
positioning  2 
8 M Level 1 Level 3 
Medical play, procedural 
support, relaxation training, 
practice with candies 1 
6 F Level 1 Level 2 
Medical play, relaxation 




Table 5: Demographics of Screened Patients vs. Patients Who Declined Screening   
 Screened Patients Patients who Decline P-value 
Average age (years) 10.09 10.22 0.918* 
% Male 38.24 50.00 0.414; 0.557** 
* P-value based on a tow-tailed two-sample t-test (assuming equal variance) 
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Appendices:  
 
Appendix 1: Pre-Selected Diagnoses for Retrospective Data Analysis  
 
Original Filtered Dx Name
ABSCESS OF ANAL AND RECTAL REGIONS  -  566
ABSCESS OF EYELID  -  373.13
ABSCESS OF SALIVARY GLAND  -  527.3
ACUTE MASTOIDITIS WITHOUT COMPS  -  383.00
ACUTE OSTEOMYEL PELVIC REGION&THIGH  -  730.05
ACUTE OSTEOMYELITIS OTHER SPEC SITE  -  730.08
ACUTE OSTEOMYELITIS SHOULDER REGION  -  730.01
ACUTE OSTEOMYELITIS SITE UNSPEC  -  730.00
ACUTE OSTEOMYELITIS, ANKLE AND FOOT  -  730.07
ACUTE OSTEOMYELITIS, LOWER LEG  -  730.06
ACUTE OSTEOMYELITIS, UPPER ARM  -  730.02
ACUTE PARAMETRITIS&PELV CELLULITIS  -  614.3
BRONCHOPNEUMONIA ORGANISM UNSPEC  -  485
CELLULITIS AND ABSCESS OF BUTTOCK  -  682.5
CELLULITIS AND ABSCESS OF FACE  -  682.0
CELLULITIS AND ABSCESS OF NECK  -  682.1
CELLULITIS AND ABSCESS OF TRUNK  -  682.2
CELLULITIS PHARYNX OR NASOPHARYNX  -  478.21
CELLULITIS&ABSC HAND NO FNGR&THUMB  -  682.4
CELLULITIS&ABSC UPPER ARM&FOREARM  -  682.3
CELLULITIS&ABSCESS FOOT EXCEPT TOES  -  682.7
CELLULITIS&ABSCESS LEG EXCEPT FOOT  -  682.6
CELLULITIS&ABSCESS OTHER SPEC SITE  -  682.8
CELLULITIS&ABSCESS UNSPECIFIED SITE  -  682.9
CHRN/UNS PARAMETRITIS&PELV CELLULIT  -  614.4
CHRONIC OSTEOMYELITIS ANKLE&FOOT  -  730.17
CHRONIC OSTEOMYELITIS SITE UNSPEC  -  730.10
CHRONIC OSTEOMYELITIS, LOWER LEG  -  730.16
EMPYEMA WITHOUT MENTION OF FISTULA  -  510.9
FEVER  UNSPECIFIED-780.60
INTRACRAN&INTRASP ABSC UNSPEC SITE  -  324.9
INTRACRANIAL ABSCESS  -  324.0
INTRASPINAL ABSCESS  -  324.1
METHICILLIN RESISTANT PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS-482.42
MONOARTICULAR JUVENILE RA  -  714.33
ORBITAL CELLULITIS  -  376.01
OTHER ABSCESS OF VULVA  -  616.4
PARAPHARYNGEAL ABSCESS  -  478.22
PERIAPICAL ABSCESS WITHOUT SINUS  -  522.5
PERIOSTITIS W/O OSTEOMYEL OTH SITE  -  730.38
PERITONEAL ABSCESS  -  567.22
PERITONSILLAR ABSCESS  -  475
PHLEBIT&THRMBOPHLB INTRACRAN VENUS  -  325
PNEUMOCOCCAL PNEUMONIA  -  481
PNEUMONIA DUE OTHER SPEC BACTERIA  -  482.89
PNEUMONIA DUE TO OTHER VIRUS NEC  -  480.8
PNEUMONIA DUE TO RSV  -  480.1
PNEUMONIA, ORGANISM UNSPECIFIED  -  486
POLYARTICLR JUV RA CHRONIC/UNSPEC  -  714.30
POLYARTICULAR JUVENILE RA ACUTE  -  714.31
PYOGENIC ARTHRIT PELV REGION&THIGH  -  711.05
PYOGENIC ARTHRITIS, FOREARM  -  711.03
PYOGENIC ARTHRITIS, MULTIPLE SITES  -  711.09
PYOGENIC ARTHRITIS, UPPER ARM  -  711.02
RETROPHARYNGEAL ABSCESS  -  478.24
SWELLING MASS OR LUMP IN HEAD&NECK  -  784.2
SWELLING OR MASS OF EYE  -  379.92
SYSTEMIC LUPUS ERYTHEMATOSUS  -  710.0
UNSPEC CELLULITIS&ABSCESS FINGER  -  681.00
UNSPEC LOCAL INF SKIN&SUBCUT TISSUE  -  686.9
UNSPEC OSTEOMYEL SHOULDER REGION  -  730.21
UNSPEC OSTEOMYELITIS ANKLE&FOOT  -  730.27
UNSPEC OSTEOMYELITIS MULTIPLE SITES  -  730.29
UNSPEC OSTEOMYELITIS OTH SPEC SITES  -  730.28
UNSPEC OSTEOMYELITIS SITE UNSPEC  -  730.20
UNSPECIFIED BACTERIAL PNEUMONIA  -  482.9
UNSPECIFIED CELLULITIS&ABSCESS TOE  -  681.10
UNSPECIFIED MASTOIDITIS  -  383.9
UNSPECIFIED OSTEOMYELITIS LOWER LEG  -  730.26
UNSPECIFIED OSTEOMYELITIS UPPER ARM  -  730.22
UNSPECIFIED OSTEOMYELITIS, FOREARM  -  730.23
UNSPECIFIED VIRAL PNEUMONIA  -  480.9
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Appendix 2: Final List of Diagnoses in Retrospective Data Analysis 
 
Txn Dx1 Name Number of Patients
ABSCESS OF EYELID  -  373.13 4
ABSCESS OF SALIVARY GLAND  -  527.3 1
ACUTE OSTEOMYEL PELVIC REGION&THIGH  -  730.05 2
ACUTE OSTEOMYELITIS OTHER SPEC SITE  -  730.08 2
ACUTE OSTEOMYELITIS, LOWER LEG  -  730.06 4
BRONCHOPNEUMONIA ORGANISM UNSPEC  -  485 7
CELLULITIS AND ABSCESS OF BUTTOCK  -  682.5 2
CELLULITIS AND ABSCESS OF FACE  -  682.0 5
CELLULITIS AND ABSCESS OF NECK  -  682.1 3
CELLULITIS AND ABSCESS OF TRUNK  -  682.2 7
CELLULITIS&ABSC HAND NO FNGR&THUMB  -  682.4 5
CELLULITIS&ABSC UPPER ARM&FOREARM  -  682.3 12
CELLULITIS&ABSCESS FOOT EXCEPT TOES  -  682.7 9
CELLULITIS&ABSCESS LEG EXCEPT FOOT  -  682.6 40
CELLULITIS&ABSCESS OTHER SPEC SITE  -  682.8 3
CELLULITIS&ABSCESS UNSPECIFIED SITE  -  682.9 9
CHRN/UNS PARAMETRITIS&PELV CELLULIT  -  614.4 1
CHRONIC OSTEOMYELITIS ANKLE&FOOT  -  730.17 1
CHRONIC OSTEOMYELITIS SITE UNSPEC  -  730.10 1
CHRONIC OSTEOMYELITIS, LOWER LEG  -  730.16 1
FEVER  UNSPECIFIED-780.60 223
INTRACRAN&INTRASP ABSC UNSPEC SITE  -  324.9 1
INTRASPINAL ABSCESS  -  324.1 1
MONOARTICULAR JUVENILE RA  -  714.33 1
ORBITAL CELLULITIS  -  376.01 8
PARAPHARYNGEAL ABSCESS  -  478.22 1
PERIAPICAL ABSCESS WITHOUT SINUS  -  522.5 1
PERITONEAL ABSCESS  -  567.22 3
PERITONSILLAR ABSCESS  -  475 1
PHLEBIT&THRMBOPHLB INTRACRAN VENUS  -  325 1
PNEUMOCOCCAL PNEUMONIA  -  481 2
PNEUMONIA DUE OTHER SPEC BACTERIA  -  482.89 2
PNEUMONIA DUE TO OTHER VIRUS NEC  -  480.8 2
PNEUMONIA DUE TO RSV  -  480.1 1
PNEUMONIA, ORGANISM UNSPECIFIED  -  486 101
POLYARTICLR JUV RA CHRONIC/UNSPEC  -  714.30 8
PYOGENIC ARTHRIT PELV REGION&THIGH  -  711.05 1
PYOGENIC ARTHRITIS, MULTIPLE SITES  -  711.09 1
PYOGENIC ARTHRITIS, UPPER ARM  -  711.02 1
RETROPHARYNGEAL ABSCESS  -  478.24 1
SWELLING MASS OR LUMP IN HEAD&NECK  -  784.2 3
SWELLING OR MASS OF EYE  -  379.92 2
SYSTEMIC LUPUS ERYTHEMATOSUS  -  710.0 31
UNSPEC CELLULITIS&ABSCESS FINGER  -  681.00 2
UNSPEC LOCAL INF SKIN&SUBCUT TISSUE  -  686.9 7
UNSPEC OSTEOMYEL SHOULDER REGION  -  730.21 1
UNSPEC OSTEOMYELITIS ANKLE&FOOT  -  730.27 5
UNSPEC OSTEOMYELITIS OTH SPEC SITES  -  730.28 9
UNSPEC OSTEOMYELITIS SITE UNSPEC  -  730.20 2
UNSPECIFIED BACTERIAL PNEUMONIA  -  482.9 10
UNSPECIFIED OSTEOMYELITIS UPPER ARM  -  730.22 2
UNSPECIFIED OSTEOMYELITIS, FOREARM  -  730.23 1
UNSPECIFIED VIRAL PNEUMONIA  -  480.9 7
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